Forxiga approved in China for the treatment of chronic kidne

Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

astrazeneca.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from astrazeneca.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Guangzhou , Guangdong , Japan , United States , Cambridge , Cambridgeshire , United Kingdom , Astrazeneca Forxiga , Centers For Disease , National Institute Of Diabetes , Southern Medical University , Nasdaq , Company On Twitter Astrazeneca , National Kidney Foundation , China National Medical Products Administration , Astrazeneca , European Union , National Medical Products Administration , Yifan Hou , Mene Pangalos , Executive Vice President , New England Journal , Rare Diseases , Disease Control , Global Burden , Disease Study , Chronic Kidney , Digital Experience , Kidney Foundation , Kidney Disease , Curr Cardiol , Kidney Diseases , Dapagliflozin Effects , Cardiovascular Events , Patients With , Acute Heart Attack ,